Drug intelligence / Profile preview

vasoactive intestinal peptide

Development stage
Phase 1
Lead developer
Relief Therapeutics
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intravenous, Inhalation, Subcutaneous
01

Overview

Vasoactive intestinal peptide (VIP) is a naturally occurring 28-amino-acid neuropeptide hormone belonging to the glucagon/secretin superfamily. It is widely distributed in the body, including the gut, pancreas, central and peripheral nervous systems. VIP acts primarily through two class B G protein-coupled receptors—VPAC1 and VPAC2—to mediate diverse physiological effects such as vasodilation, smooth muscle relaxation (notably in the gastrointestinal tract), stimulation of water and electrolyte secretion from exocrine glands (pancreas and bile), inhibition of gastric acid secretion, modulation of immune responses via anti-inflammatory actions, enhancement of glucose-dependent insulin secretion from pancreatic β-cells, promotion of β-cell proliferation, neuroprotection in the CNS, regulation of circadian rhythms via action on suprachiasmatic nuclei neurons in the brain, and cardiovascular effects including coronary vasodilation[4][5][6][8]. Synthetic forms like Aviptadil have been developed for clinical use.

Other names
vasoactive intestinal polypeptideVIP
02

Targets

VIPR2 (Vasoactive intestinal polypeptide receptor 2)VIPR1 (Vasoactive intestinal peptide receptor 1)

Beyond the preview

Go deeper on vasoactive intestinal peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vasoactive intestinal peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call